MedPath

Clinical Performance of a Glass Hybrid Restorative in NCCL's of Patients With Bruxism

Not Applicable
Conditions
Noncarious Cervical Lesions
Bruxism
Interventions
Device: tooth restoration
Registration Number
NCT03713827
Lead Sponsor
Hacettepe University
Brief Summary

This is a double blinded, split mouth, randomized clinical study that evaluated the performance of a glass hybrid restorative material in non-carious servical lesions in patients with bruxism. The lesions were restored with glass hybrid restorative (Equia Forte) or nano ceramic composite resin (Ceram-x One). Restorations were evaluated after 24 months according to USPHS criteria and the data were evaluated.

Detailed Description

The aim of this study was to evaluate the clinical performance of a glass-hybrid-restorative compared with a nano ceramic composite resin in non-carious cervical lesions (NCCLs) of patients with bruxism.

For this purpose, twenty-five patients having NCCLs and bruxism enrolled to the present study. Before treatment, the dimensions of the NCCLs were measured in depth, gingival-incisal height and mesio-distal width using a CPI probe. Degree of tooth wear (TWI) and gingival conditions (GI) are also recorded. A total of 148 NCCLs were randomly restored with a a glass-hybrid-restorative system (Equia Forte Fil, GC, Tokyo, Japan) or a nano ceramic composite resin (Ceram.X One Universal, Dentsply, DeTrey, Konstanz, Germany) and restorations were evaluated at baseline and after 6,12 and 24 months according to the modified-USPHS criteria. Data were analyzed with Chi- Square, Fisher's Exact Test, Mann Whitney-U and Cochran's Q tests (p \< 0.05).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • non-hospitalized, healthy patients that were seeking dental treatmen
  • occlusally contacted teeth
Exclusion Criteria
  • Patients having intensive medical history
  • Chronic periodontitis,
  • high caries activity,
  • extremely poor oral hygiene,
  • teeth with restorations,
  • mobility due to periodontal disease
  • in contacted with removable prosthetic construction were excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
"glass ionomer cement", "Equia Forte"tooth restorationTooth restoration with glass ionomer cement (Glass hybrid restorative system) "Equia Forte"
"composite resin", "Ceram-x One Universal"tooth restorationtooth restoration with nano-ceramic composite resin "Ceram-x one Universal"
Primary Outcome Measures
NameTimeMethod
Retention Alpha for at least 90% of the restorations24 months

The primary factor for determining the clinical performance of a restorative material is the retention rate. It represents the survival rates of the restorations after a period of time. According to ADA guidelines, a restorative material should show at leat 90% alpha retention rate after 18 months to be considered as clinically acceptable. The retention is assesed as alpha (retentive restoratation) or charlie (failed restoration). Clinical evaluation is performed to examine if the restoration is in place or has fallen.

Secondary Outcome Measures
NameTimeMethod
marginal adaptation score alpha24 months

It represents the marginal integrity of the restorations. It is scored as alpha (perfect marginal adaptation), bravo (detectable marginal discrepency, clinically acceptable) or charlie (marginal crevice, clinically unacceptable). The examination of marginal adaptation is performed by clinical examination of the restoration with probe.

© Copyright 2025. All Rights Reserved by MedPath